Regional CMR g lc was measured in seven healthy volunteers with positron emission tomography using [I-IIC]D-glucose. Regional CBF was measured us· ing [IIC]fluoromethane. The arteriovenous differences of unlabeled glucose and oxygen together with IIC metabo lites were also measured. In addition to the loss of [llC]COZ' a loss of acidic IIC metabolites was also de tected. A three-compartment model was applied to the tracer data in the time interval 0-24 min. After correction for the loss of IIC metabolites, the tracer method gave an average CMR g lc of 26.4 ± 1.9 (SD) ILmoVIOO g/min, close to the value obtained with the Fick principle. After cor rection for the loss of [IIC]COZ only, the tracer method gave 23 .6 ± 2.1 ILmoVIOO g/min, compatible with (116) CMROz, obtained with the Fick principle. These results and the time course of the loss of acidic IIC metabolites are consistent with the presence of nonoxidative metab-Abbreviations used: A VD, arterial-jugular vein diffe rence; BBB, blood-brain barrier; CT, computed tomography; [llClDG, ['8FlFDG, [llClFM, [llClfluoromethane; HPLC, high-perfo r mance liquid chromatography; LC, lumped constant; PET, pos itron emission tomography; rC BF, regional cerebral blood flow; rCBV, regional cerebral blood volume; rCMRgl c' regional cere bral metabolic rate of glucose; tion, the loss of P IC]COZ was substantially delayed and the contrast between gray and white matter was im proved. A kinetic model for [I-llC]D-glucose for use in PET studies without the simultaneous measurement of rCBF and the loss of IIC metabolites is proposed.
Presently, almost all investigations of regional ce rebral glucose metabolism (rCMRglc) with positron emission tomography (PET) are performed using the glucose analogs [1_1 1 C]2-deoxy-D-glucose ([llC]DG) or [2-1 sp]2-fluoro-2-deoxY-D-glucose (esp] PDG). The tracer model for [llC]DG, origi nally developed fo r autoradiography with 1 4C olism of glucose that causes an early loss of mainly [IIC]lactate after a bolus injection of the tracer. This im plies that [I-IIC]D-glucose measures the rate of glucose oxidation rather than the total CMR g lc' The experiments using fI-IIC]D-glucose were compared to five analogous experiments using [U _IIC]D-glucose together with [150]H20 as a flow tracer. After correction for the loss of [IIC]COZ' the two glucose tracers gave similar global val ues of CMR g lc and other parameters associated with glu cose utilization, but with labeling in the carbon-I posi (Sokoloff et aI ., 1977) , has been successfully adapted for dynamic PET studies with eSp]PDG (Reivich et aI ., 1977 ; Phelps et aI ., 1978) and [llC] DG (Reivich et al., 1982) . The labeled analogs are effectively trapped in the tissue after the phos phorylation step and the rate of phosphorylation can be calculated. However, the use of glucose an alogs to study glucose utilization is not free from problems. The corresponding tracer models neces sarily involve a so-called "lumped constant" (LC) , which must be determined in order to convert the measured metabolic rates obtained for the analogs into rCMRglc • The necessary measuring time is comparatively long, 45 min or more for [lsp]PDG , and it may be difficult to maintain the necessary steady-state conditions throughout this time period. Physiological parameters related to CMRglc, such as the glucose concentration in tissue and the uni directional glucose influx over the blood-brain barrier (BBB), are not directly measurable with [1lC]DG or eSF]FDG .
The above problems with glucose analogs are overcome when using the natural substrate as the tracer for investigation of glucose utilization, llC_ labeled D-glucose. However, values of CMRglc ob tained with this tracer are considered to be inaccu rate because of the rapid loss fr om the tissue of llC-labeled metabolites, in particular [IlC]C02, ex pected from the rapid metabolism of this tracer. De spite problems with this loss, llC_ and 14C-labeled D-glucose have been used to some extent for mea suring rCMRglc and related physiological quantities. Glucose labeled with equal probability in all carbon positions, [V-llC] D-glucose ([V_llC]gIc), has been used in CMRglc investigations in monkeys (Raichle et aI ., 1975 (Raichle et aI ., , 1978 Blomqvist et aI ., 1985) and also in humans (Mintun et aI ., 1985 ; Wiesel et aI ., 1987 ; Wik et aI ., 1988 ; Gutniak et aI ., 1990) . Hawkins and collaborators (Hawkins et aI ., 1979 (Hawkins et aI ., , 1985 Lu et aI ., 1983) have reported studies of the use of D-glucose specifically labeled with 14C in the 1, 2, or 6 position for autoradiographic measurement of rCMRglc . This study indicated that the time course for the loss of e4C]C02 fr om the tissue could be controlled by the choice of the labeling position. Bqlindsted and Gj edde (1988) have used [6-14C] glucose in studies of CMRglc in rats.
In this report, we describe a method to use D glucose selectively labeled in the carbon-l position, [1-11C]D-glucose ([I-llC]gIc), for measurement of rCMRglc with PET. A correction method for the regional loss of llC metabolites, based on the mea sured arterial-internal jugular vein difference (AVD) and regional cerebral blood flow (rCBF), was applied. To validate the method, CMRglc was also determined from the measured A VD in unla beled glucose and from CBF. CMR02 was calcu lated analogously. To investigate the effect of the reduced loss of e lC]COz, the results obtained using [I-llC] glc were also compared to corresponding ones obtained using [V-llC] glc. A kinetic model that makes possible the use of [I_ 11C]glc without the simultaneous rCBF and A VD measurements is briefly examined.
METHODS

The model
In the compartment model applied, the local region is considered to be homogeneous with respect to rCBF and transport constants of glucose and its metabolites. The system under consideration is assumed to be in steady state, implying that the fractional transfer rates (rate con stants) and the concentrations in different stages of the J Cereb Blood Flow Metab, Vol, 10, No, 4, 1990 metabolic chain do not change with time. It is assumed that the amount of unlabeled glucose injected together with the labeled glucose does not disturb this steady state. The tracer is considered to be either in the plasma as [I_lIC]D-glucose (P ), in the tissue as [l-lIC]D-glucose (precursor pool, E), or in the tissue as various IIC-labeled metabolic products (the tissue metabolic pool, M). Thus, no discrimination between extra-and intracellular free glucose is made (cf. Lund-Andersen, 1979) . There is a loss from the metabolic compartment to the bloodstream. The dephosphorylation of glucose-6-phosphate back into glucose is neglected. The possibility of such a "futile cycle" has been discussed at length in connection with the use of glucose analogs [IIC]DG and [18F]FDG . It now appears as though this effect can also be neglected for natural glucose in the brain (Nelson et ai., 1985; Dienel et ai., 1987) .
The following equations describe the time course of the tracer activities in the precursor and metabolic pools (co ordinates describing the regional dependence are sup pressed):
The symbols C� and C� denote the tracer radioactivity per unit weight of tissue (nCi/g) in compartments E and M, respectively, and C� denotes the radioactivity of [11C]glucose per unit volume (nCilml) of arterial plasma. The quantity dC'{Jt)ldt in Eq. (2) describes the loss of tracer per unit time and unit mass of tissue (nCilg/min). In Eq. (1), the expression K I C�(t) -k2 CMt) is the net flux of tracer across the BBB and k3 C�(t) is the rate of phos phorylation (Gjedde, 1982) . The parameters K I (mUg/min) and k2 (min -I) are the rate constants for the transport of (labeled and unlabeled) glucose across the blood-brain barrier, respectively, and k3 (min -I) is the rate constant for phosphorylation. If the loss of tracer from the tissue were negligible, the tracer equations would be equal to those for [14C]DG when LC equals 1 (Sokoloff et ai., 1977) .
When the initial conditions, CMO) = C�(O) = 0, are taken into account the solution to the system of Eqs. (1) and (2) is (4) The concentration of lIC metabolites in the tissue at time T is thus expressed as the difference between the amount of lIC metabolites produced and the cumulative loss, CL(n, of the tracer. The radioactivity concentration mea sured by the camera is related to the concentrations of labeled compounds in the blood, precursor, and tissue metabolite compartments by the following:
The term C�I(t) is the radioactivity in blood and rCBV is � he regional cerebral blood volume. In this connection, it IS assumed that, due to the comparatively small extrac tion fraction of glucose, the difference in tracer concen trations in venous and arterial blood can be neglected.
The regional rate of loss of IIC metabolites from the brain tissue, dCt(x,t)ldt, can be expressed in terms of rCBF and the arterial-jugular vein difference (A VD) of these metabolites, AVD(C;;'et) :
Here and throughout this paper, x denotes the depen dence on the structure studied. Under steady-state con ditions, the metabolites produced by glucose metabolism are lost from the brain at the same rate as glucose is consumed. If all glucose were oxidized to CO2, the fol lowing relation between rCMRglc (in fLmol/100 g/min), rCBF (in ml/l00 g/min), and the AVD of unlabeled CO2 (in fLmol/ml) would be valid :
The presence of other metabolic pathways besides total glucose oxidation implies that the right-hand side of Eq. (7) should be replaced by a sum of terms, one for each metabolite. Each term is a product of rCBF, the AVD of the metabolite, and a proportionality factor different from 1/6. Under normal resting conditions, rCMRglc and rCBF are strongly coupled (Baron et aI., 1984) and, therefore, according to Eq. (7), the regional AVD of the unlabeled metabolites will not differ appreciably from their measur able averages. After injection of the tracer, the specific activities of the various labeled compounds will approach constant values with increasing time, which implies that the A VD of various II C metabolites are expected to have small regional variations after a sufficiently long time. Therefore, assuming normal conditions, the unobservable regional A VD of various IIC metabolites can be approx imated with the average for the whole brain, and the re gional cumulative loss of IIC metabolites, ctex, 1), can then be expressed in terms of rCBF and the measurable brain average A VD in IIC metabolites as
This expression is used in the present study to correct for the regional loss of tracer. The applied correction method requires measurement of rCBF and the A VD of the dom inating IIC metabolites. The regional variation in the loss of these metabolites is thus ascribed entirely to the rCBF variation. After a bolus injection, regions with large rCMR J! 1c will produce metabolites faster than regions with low rcMRglc' Therefore, relation (8) may not be valid during the first time period after the bolus administration of the tracer, but the A VD of IIC metabolites is of minor importance then anyway, especially in experiments using [1-IIClglc.
Measurements and data processing
[l-IIClD-Glucose was synthesized (Stone-Elander et ai., 1989) in a two-step reaction from [IIC]ammonium cy-anide by a modification of the method reported by Shiue and Wolf (1985) . To isolate [l _ IIClglc from [l-IIC]D mannose and other radioactive impurities, high-perfor mance liquid chromatography (HPLC) with an Aminex HPX-87P column was used. The product obtained was shown to be >99% radiochemically pure by analytical radio-HPLC. The labeling of glucose with the IIC distrib uted uniformly in all positions has been described by Ehrin et al. (1983) .
In seven healthy normal volunteers, rCMR I was measured with [l-IIC]glc and the rCBF with (Stone-Elander et aI., 1986) . In five healthy normal volunteers, rCMR I was measured with [U-IIC]glc and rCBF with [150]H/)� To identify an atomical regions in the brain, a CT scan was performed prior to the PET examination. To allow identical position ing of the subject in the different investigations, a special head fixation device was used (Bergstrom et ai., 1981) . After the CT scan, the subject was transferred to the positron camera. The first PET measurement was per formed about 2 h after the last meal. Prior to the PET measurements, a catheter was placed under fluoroscopic control in the bulbus vena jugularis for sampling of ve nous blood from the brain. Another catheter was placed in the arteria brachialis for arterial blood sampling. A cannula was placed in a brachial vein for injection of the tracer. During the study, the subjects were in a resting state with their eyes covered, except in the three exper iments with measurement of acidic IIC metabolites when local activation (voluntary movements of the fingers of the right hand) was performed.
The PET scanner used was a four ring positron camera (Scanditronix PC384-7B) with a spatial resolution in the plane of 7.8 mm and a line spread function in the axial direction of 11 mm full width at half-maximum (Eriksson et aI., 1982) . The injected radioactivity of [1-IIC]glucose or [U-IIC]glucose in each experiment was 200-300 MBq. Following a bolus injection, camera data were collected during 24 min. The total PET measuring time was divided into 6 scans of 20 s, 3 scans of 40 s, 4 scans of 2 min, and 3 scans of 4 min duration, 16 time intervals in all. The total time period for an examination, including time for placement of the catheter in bulbus vena jugularis, the measurement of CMR g lc, and the rCBF measurement, was =4.5 h. Before and after each examination, samples were also taken for the determination of PaC02 and pH.
The radioactivity in arterial blood and plasma was de termined simultaneously with the PET measurement. In experiments with [1-IIC]glc, an automatic blood sampling system was utilized (Eriksson et ai., 1988) . With this de vice, the radioactivity in whole blood was sampled in I-s intervals and stored in a computer file for subsequent processing together with the PET data. The withdrawal rate was 5 ml/min. To reduce the blood loss, the measur ing time using this device was limited to 10 min. During the remaining measuring time, five I-ml samples of arte rial blood were drawn manually. In order to calibrate the automatic device, four I-ml samples of arterial blood were also drawn during the first 10 min. The manual sam ples were measured during 10 s in a NaI well counter that ! n turn, was cross-calibrated in advance against the pos : Itron cam�ra. To determine the radioactivity in full blood, a small aliquot (0.2 ml) was taken from each manually drawn blood sample and measured in the well counter. To determine the radioactivity in plasma, the remaining part of the blood sample was centrifuged and thereafter a sam ple of plasma (0.2 m!) was measured in the well counter.
With the aid of the manual measurements, the ratio between the radioactivities in plasma and full blood was determined as a function of time and subsequently used to transform the measurements made by the automatic de vice into plasma radioactivity. The manual arterial sam ples were taken from a three-way valve connected di rectly to the catheter inserted in the artery. From the same valve, blood was also pumped to the automatic measuring device in a 60 cm long catheter. To be able to compare the measurements made in the well counter and in the automatic device, the transport time in the catheter had to be accounted for. With the applied withdrawal rate, the delay was = 10 s and was determined in each experiment by inspection of the deviations between the manual and automatic measurements. Also, the delay be tween the arrival of the radioactivity to the brain and to the automatic blood measuring device had to be ac counted for. Since the total number of valid counts per second in the camera was stored together with the counts from the blood measuring device, the time shift between blood and camera measurements could be determined. This shift was applied to the blood measurements.
When [U-llClglc was used, camera data were collected during 24 min divided into 18 consecutive time intervals gradually increasing from 20 s to 3 min (the data collec tion was continued during another 21 min, but for com parison purposes these data are not included in the anal ysis here). Twenty I-ml samples of arterial blood were drawn manually with gradually increasing time intervals. From these, the radioactivity in full blood and plasma was measured in the well counter.
In four cases using [1-llC]glc and in all five cases using [U-llC]glc as tracers, the time course of the AVD of [llC]C02 was measured during the examination. Eight I-ml samples were drawn at different times of both arte rial and venous blood (the latter from the catheter in the jugular vein). The [llClC02 content in the blood was mea sured according to Nilsson et al. (1985) . In three of the examinations with [1-llClglc, the fraction of llC-labeled acidic metabolites in blood was measured. For this pur pose, five 3 ml samples were simultaneously drawn from arterial and jugular blood at timed intervals. The percent age of llC-labeled acidic metabolites was determined es sentially as described by Kreisberg et al. (1970) . In brief, plasma (0.5 m!) was applied to an ion exchange column (Dowex IX2, acetate form, length of 20 mm and diameter of 5 mm) and eluted with water (2 ml). Acidic compounds are retained on this type of column. The radioactivities in the column and the eluate were measured in the well counter. For the first sample, >99% of the radioactivity was found in the eluate, which is as expected since the radioactive component should primarily be glucose early after injection. The radioactivity retained on the column with later samples is taken as a measure of acidic metab olites.
Eight samples were also taken to determine the glucose concentrations in arterial and jugular blood and in arterial plasma by a standard glucose oxidase method (godpap). When [l-llClglc was used, samples were also taken to determine the oxygen content according to the method described by Siggard-Andersen (1977) . When sampling from the jugular bulb, 6 ml of blood were always first drawn before the actual sample was taken. This was done in order to correct for the "dead space" of the catheter J Cereb Blood Flow Metab, Vol. 10, No. 4, 1990 that reached from the femoral vein to the jugular bulb. These 6 ml were thereafter reinjected to reduce the blood loss.
To estimate the amount of IIC metabolites in the arte rial blood at arbitrary times, a biexponential expression was fitted to the fractions of metabolitesfmeit) measured at different times ti,
When [1_llClglc was used, the arterial plasma radioactiv ity was corrected for the contribution both from [IIClC02 and acidic llC metabolites. When [U-llC]glc was used, labeled metabolites other than [llClC02 were not mea sured and, therefore, the arterial radioactivity concentra tion was only corrected for the contribution of [IIClC02• Because the metabolite correction was found to be small, the possible difference between whole blood and plasma in the fraction of metabolites was neglected. After cor rection for IIC metabolites, the remaining radioactivity in arterial plasma was considered to be due to [llC]glucose and used as the "input function" in the model fit [cf. Eqs.
( 3) and (4)].
The ratio between the radioactivity in plasma and whole blood was found to decrease slowly and almost linearly with increasing time when [I I Clglucose was used (see below in the results section). Consequently, a straight-line fit was applied to this ratio. The fitted pa rameters were used to transform the radioactivity in the whole blood, measured by the automatic blood sampling system, into plasma radioactivity. Maps of the spatial ra dioactivity in the examined time intervals were recon structed in the form of 128 x 128 matrices for each slice employing methods described elsewhere (Bergstrom et aI., 1982) . To obtain the regional tissue radioactivity con centration, the measurements with [llC]glucose were cor rected for the small contribution from the blood [E q. (5)]. This correction was obtained from the measured time course of the radioactivity in whole blood (in nCi/m!) mul tiplied by an average CBV, taken to be 0.04 ml of blood/(g of tissue) (P helps et aI., 1979). The influence of the re gional variation in CBV was thus ignored. The exact rCBV value used in Eq. (5) has little influence on the rCMR g lc estimate, because this parameter is mainly de termined from the rate of change, and not from the abso lute value, of the tissue radioactivity (see the Discussion section).
For the measurements of rCBF, 1,850 MBq of [IIClFM was inhaled as a bolus (Roland et aI., 1987) . The total measuring interval was 3 min divided into consecutive lO-s intervals. The arterial radioactivity was measured with the automated blood sampling system. For the mea surements using p50]H20, a bolus of 1,800 MBq was injected into an arm vein. The radioactivity in the brain was measured with the camera during 9 min divided into consecutive 20-s intervals. Arterial blood samples were drawn manually, and the radioactivity was measured in the well counter. In this case, the data in the time period �2 min after tracer administration was utilized.
To calculate rCBF, the algorithm by Koeppe et al. (1985) was applied. The CBF values obtained with [150]H20 as a flow tracer were corrected for the limited extraction of water from the following empirical relation between the observed and corrected flow values, CBF obs and CBFtrue, respectively (E ichling et aI., 1974):
where EH is the single pass extraction fraction of water into the brain. Before and after the rCBF determinations, blood samples were also taken for the determination of PaCOz and pH.
The A VD measurements of [IIC]metabolites were pa rameterized as follows:
Using this parameterization and the measured rCBF, the accumulated, regional loss of IIC metabolites, CL * (n, could be estimated at the midpoints of the time intervals used in the PET measurement. To obtain the time activity curve of a region, the average of the decay corrected radioactivity concentration (in nCi/ml) of the picture elements within the region was calculated at the different time points (midpoints of the time intervals) se lected. For each examined subject, three regions of inter est were defined: one containing the whole brain and the two other containing representative gray and white mat ter areas in the slices (5) and (6). The contours defining the regions were drawn with the aid of an image processor (Ramtec) on the CT images corresponding to each of the seven PET slice images. The format of the CT images was transformed to the format of the PET images.
With the expressions (3) and (4) for Ci!.(n and C�(t) inserted, Eq. (5) gives a relation between the measure ments Cbb,en, C�len, C;en, and C't(n, on the one hand, and the rate constants K I > kz, and k3' on the other. These unknown parameters were estimated through a least squares fit of the right-hand side ofEq. (5) to Cbb,(n in all time intervals. To allow fast calculation of the convolu tion integrals in Eqs. (3) and (4), the input function C;(t),
i.e., the radioactivity in the plasma, corrected for IIC metabolites, was fitted with a sum of exponentials. The minimization of the least-squares sum through variation of the three rate constants was performed iteratively by a standard technique (James and Roos, 1975) . Maps of rCMR gl c [= Cp K I k3/(kz + k3)] were constructed using a linear least-squares algorithm (Blomqvist, 1984) en abling a fast direct estimate of rCMR gl c. In this case, a numerical integration of the input function was per formed. The method eliminates the need to calculate con volution integrals. For any region, the nonlinear, iterative and the linear, noniterative methods give very similar val ues of rCMR gl c.
An independent determination of the average CMR gl c was obtained from the measured A VD of the whole blood glucose concentration and the average CBF. Similarly, the average rate of oxygen consumption, CMROz, was determined from CBF and the A VD of the oxygen con tent in blood.
RESULTS
The loss of [1lC]C02 and acidic llC metabolites Figure 1 illustrates the blood measurements for one case. The well counter data ( Fig. la) , trans fo rmed into nCi/ml, shows that the ratio between the radioactivity concentrations in plasma and 15 20 25 min This numerical relation was used to transform the whole blood radioactivity, measured by the auto matic blood sampling system, into plasma radioac tivity. As a comparison, the ratio between the con centrations of unlabeled glucose in plasma and fu ll blood was found to be 1.16 ± 0.2. Immediately after the injection of tracer, all radioactivity must be in the plasma, which means that the ratio between the radioactivities in fu ll blood and plasma probably is larger than 1.2 when the bolus reaches the brain. In the subsequent calculations, the effect of a possible diffe rent ratio during the initial time period is ne glected. This approximation has a minor influence on the estimate of rCMRglc , because it is mainly the data at late times that influence the estimate of this quantity (see the Discussion section) . Figure Ib shows the measured concentrations of [1lC]C02 and llC acidic metabolites in arterial and venous blood. These measurements were used to correct the plasma radioactivity for IIC metabolites and, together with the rCBF measurement, to cor rect for the loss of [llC] metabolites from the tissue. Figure lc illustrates the combination of the auto matic and well counter measurements of the plasma radioactivity. The derived empirical relation be tween the radioactivities in blood and plasma (Fig. la ) was used to transform the measurements in fu ll blood made by the automatic device. The first man ual fu ll blood measurements, sampled while data 1990 ) were still collected by the automatic device, were used to find the calibration factor between the au tomatic device and the well counter. The manual measurements were in this case displaced 12 s to account for the transport time in the catheter lead ing from the arm to the automatic measuring device. Both the manual and automatic measurements were corrected for the measured fraction of IIC metabo lites in the arterial blood. The time-activity data shown were used as the "input function" C;(t) for this case in the model equations (3) and acidic lIC metabolites are also shown. Clearly, the loss from the tissue of labeled metabolites other than [1IC]C02 is important. The curves were ob tained with the parameterization in eq. (11) and used for interpolation purposes in the subsequent corrections of the measured tissue radioactivities (see the Measurements and Data Processing sec tion) . In the fo llowing, the PET measurements are always corrected for the loss of [1IC]C02 fr om the brain. In the case of [l-lIC]glc, an additional cor rection for the loss of acidic IIC metabolites can also be made based on the measured A VD for these labeled metabolites. It is explicitly stated, or other wise clear fr om the context when this additional correction has been made . Figure 4 shows the ratio (in min -I) between the rate of loss of IIC metabolites from the brain, cal culated with Eq. (6), and the concentration of l 1 C metabolites remaining in the tissue, C�(t), esti mated with the aid of Eq. (4) . For [lIC]C02, this ratio has only a weak time dependence when glc is used, which shows that the rate of egress of [1IC]C02 for this tracer is on average nearly proportional to the concentration of lIC me tabolites in the tissue. The ratio in the time interval 5-24 min was found to be (sample mean ± SEM) 0.0060 ± 0.0003 min -I . In contrast, for acidic l 1 C metabolites, the ratio is seen to vary somewhat with time . When [U-lIC]glc is used, the ratio (calculated for [1IC]C02) varies rapidly in the interval 0-15 min. Figure 5 shows the percentage of IIC metabolites of the total radioactivity in the arterial plasma mea sured at different times. For [l-l 1 C]glc , where the percentages of both [1IC]C02 and acidic IIC metab olites were measured, the sum of these components is shown as well as the measurements of e IC]C02 only . Clearly , the major part of the arterial plasma
.20 metabolites is not e IC]C02. The curve , which is a fit of the expression (9) to the data, is used to cor rect the measured radioactivity concentration in ar terial plasma. With [I-I\C]gIc , the percentages of [1IC]C02 and acidic I\C metabolites in arterial plasma are observed to be very different in magni tude, whereas the accumulated losses from the brain of these metabolites are of the same order of magnitude (Fig. 3 ). This shows that the clearance of these acidic metabolites fr om the blood is slow compared to the rate of loss of CO2 from the lungs. With [U-IIC]gIc , the fr action of acidic IIC metab olites was not measured but only [1IC]C02 and , consequently, the arterial plasma radioactivity was only corrected for [1IC]C02 in this case. The curve is again a fit of the expression (9) .
CMRglc and other physiological parameters Figure 6 illustrates the fit of the model to the data for one examination using [I-IIC]gIc . The estimated concentrations of tracer in the blood (scaled with CBV to get the vascular contribution to the radio activity concentration measured in the camera) in the precursor pool [Eq. (3)] , and in the metabolic pool [Eq. (4)] are shown as curves. The radioactiv ity measured at different times in the camera is also given together with the corresponding data cor rected for the combined losses of [1IC]C02 and acidic IIC metabolites. The indicated times are the midpoints of the measuring intervals in the camera. Equation (11) was used to estimate the accumulated loss of IIC metabolites at these times. The curve through the corrected measurement points is the fit of the model. Evidently , there is a good agreement between the model and data over the whole time interval considered. The correction for loss of lIC metabolites is seen to be practically negligible dur ing the first 5 min after the injection. The concen tration of IIC metabolites remaining in the tissue is seen to increase rapidly and to become the domi nant part of the tissue radioactivity already after 10 min. At this time , the ratio between the radioactiv ities in the M and E compartments was found to be 4.0 ± 1.2 (SD). As a comparison, this ratio was fo und to be only 0.8 ± 0.1 for [IIC]DG at the same time (Reivich et aI ., 1982) . To achieve a reliable estimate of CMRglc with a tracer method, a substan tial amount of the tracer must be metabolized dur ing the measuring time. Consequently, to determine CMRglc with a prescribed precision, [1-I\C]gIc re quires a shorter measuring time than the glucose analogs. (10)] , the CBF value ob tained with e50]H20 was fo und to be 43 .5 ± 3.1 (mean ± SEM) mIl 100 g/min, and the corresponding CMRglc value was 21.3 ± 1.1 f,Lmol/ lOO g/min. To estimate the parameters based on the tracer model, the average time-activity curve for the whole brain was used. Sample averages and standard deviations are given.
The extra correction for loss of acidic IIC metab olites increases the estimated CMRglc value by 12%. If the data were corrected for the loss of [1lC]C02 only , the average CMRglc using [1-llC]glc was fo und to decrease smoothly from 24 .7 ± 0.8 (mean ± SEM) to 23 .6 ± 0.8 f,Lmol/l00 g/min when the measuring interval was prolonged fr om 0--8 min to 0-24 min . This decrease is expected to occur due to the loss of the other lIC metabolites. In accordance with the time course of this loss (Fig. 2) , the de crease was found to be most pronounced when the upper time limit was increased from 8 to = 15 min. On the other hand, if correction was made for the total loss of measured IIC metabolites, the average CMRg!c using [l-lIC]glc was found to be 26.8 ± 0.6 and 26 .4 ± 0.8 (SEM) f,Lmolll00 g/min when data in the time intervals 0--8 and 0--24 min, respectively , were utilized. This correction thus seems to take care of all losses of labeled metabolites, large enough to influence the value of the estimated CMRg!c .
As expected, when only correction for the loss of [1lC]C02 has been made , the tracer method gives a lower sample average in CMRglc compared to the Fick principle (28 .3 ± 4.3 f,Lmol/l00 g/min) . The dif ference, however, is not significant . The latter method also gives a larger SD in CMRglc than the tracer method. This means that the largest differ ences between the two methods are obtained at the highest CMRglc values, calculated by the Fick prin ciple , and also that the correlation between individ ual values obtained with the two methods is weak. These differences in CMRglc, calculated by the two methods, could be due to a lower precision (larger measurement error) of the Fick principle compared to the tracer method, since the A VD of unlabeled glucose is obtained as the difference between two comparatively large quantities. Another possible explanation could be that there is a systematic dif ference between the two methods that increases with increasing CMRglc, calculated by the Fick prin ciple . It should also be noted that 1.9, the SD of (l/6)CMR02 measured by the Fick principle, is comparable to 2.1, the SD of CMRglc measured by [l-lIC] glc and consequently smaller than the SD for CMRglc measured by the Fick principle.
The influence of cerebrospinal fluid (CSF) spaces and bone (Chawluk et al ., 1984) was neglected in the present study. The effect of these factors is to systematically underestimate CMRglc with a few percent. Reivich et al . (1985) applied a 6% correc tion to their PET data to compensate for this effect. If the same correction were applied to our data, correction for the loss of e IC]C02 only should give CMRglc equal to 25.0, and correction for the loss of all measured lIC metabolites should give CMRglc equal to 28.0 f,LmolllOO g/min. Thus, after correction for the loss of all detected IIC metabolites, CMRglc obtained with the tracer method agrees well with CMRglc measured by the Fick principle. Mt er cor rection for the loss of e IC]C02 only , CMRglc ob tained with the tracer method agrees well with 1/6 of CMR02 (25.5 ± 1.9 f,LmolllOO g/min) measured by the Fick principle.
The main purpose of this study is to examine the use of [l)IC]glc to measure CMRglc. However, to validate the method, it is important to examine other parameters obtained with this tracer. Table 1 also contains for comparison parameters obtained in studies by other investigators. In general, the re sults of the present study are in agreement with those previously reported. The rate constant K l for transport of glucose from blood to brain is quite insensitive to the exact compartmental configura tion, because the sensitivity function (Beck and Ar nold, 1977) for this parameter is largest during the initial time period after a bolus injection when the time course of the tracer is dominated by the uni directional influx across BBB. The values given in Table 1 also show that K I is affected very little (=5%) by the metabolite correction. To diminish further the influence of the loss of tracer on the estimate of this parameter, the time interval used for estimate of K I could be shortened. The single pass extraction of glucose, calculated here as K I /CBF, is found to be close to the value obtained with a different technique (Knudsen et al . , 1989) . The calculated rate of influx of glucose across the BBB observed is also in agreement with the measurements by Hertz et al. (1981) showing that only 50--60% of the glucose transported into the tissue is metabolized and the rest is transported back again into the bloodstream. To study unidirec- Quoted values are averages for the whole brain and total number of experiments. Standard deviations are given in parentheses. For [1_11C]glc, the parameters obtained with the tracer method are calculated in two ways: either by cor rection for all measured IIC metabolites or by correction for the loss of [IIC]C02 only. Tracer data in the time interval 0-24 min are used throughout. C p ' Ca, and Cy, glucose concentration in arterial plasma, arterial blood, and venous blood, respectively; CMR gl c(Fick), CBF . (Ca -Cy); CMRg1c(model), K l k3/(k2 + k3)] C p ; net extr., AVD, (Ca -Cy)/Ca, steady-state extraction fraction of glucose calculated from AVD measurements; net extr., model, CMRgl c(modei)/CBF . Ca; single pass extr., glc, single pass extraction of glucose, calculated as K/CBF (cf. Lassen and Gj edde, 1983) ; influx BBB, glc, unidirectional influx of glucose across BBB, approximated as K I . C p ; Tl/2 precursor, half-life of glucose in the precursor pool = In2/(k2 + k3); distribution vol. glc, distribution volume of glucose = K I /(k2 + k3); tissue conc . glc, [K/(k2 + k3)] C p o a From Siesj6 (1978) . b From Mazziotta and Phelps (1986) . c From Lassen (1985) . d From Gj edde et al. (1985) . tional transport of glucose across the BBB, llC_ labeled glucose is clearly the tracer of choice . There is no reason to use eSF]FDG or [1lC]DG for this purpose.
Using [l-IlC]glc, the estimated distribution vol ume of glucose has been estimated by others (Gjedde et aI., 1985) through comparison of eSF]FDG and [1lC]methylglucose, and was fo und to be somewhat larger than in this study. It should be noted that the correction for loss of acidic IIC metabolites decreases the estimate of the tissue glu cose concentration as well as the half-life of the precursor pool of unmetabolized glucose by 20%.
In general, after correction for loss of [1lC]C02 only , [1 _ 11C]glc and [U-llC]glc gave parameters that are compatible with each other, when averaged over the whole brain. As mentioned earlier, the [U-ll C]glc data were not corrected for the fraction of llC metabolites besides [1lC]C02 in the arterial plasma. In other studies using [U-llC]glc, the aver age CMRglc values were found to be close to the value presented here . Wiesel et al . (1987) fo und CMRglc to be (mean ± SD) 22.5 ± 2.1 /-Lmol/ lOO g/min in a study of nine healthy subjects. The cor re sponding values fo und by Gutniak et al . (1990) were 22.0 ± 5.3 /-Lmol/IOO g/min in eight subjects. Thus, after correction for the loss of e IC]C02, PET measurements with both [l-llC]glc and [U-l lC]gIc have given CMRglc values for the whole brain around 23 /-Lmol/lOO g/min, which varied over a nar row range . In contrast to the good agreement in the global parameter values, differences were observed FIG. 7. Example of a map of rCMRg1c' obtained with the aid of a linear least-squares algorithm (Blomqvist, 1984) for one slice and one experi ment using [1-11C]o-glucose. The injected rad io activity was 300 MBq. Measurements between 0 and 24 min were used in the calculation. The display image matrix is 256 x 256 pixels.
regionally for various parameters when [l-llC]gIc or [U-l lC]glc was used. For rCMRg1 C ' the gray to-white ratio was found to be 2.2 ± 0. 1 when using [l-llC]glc, whereas the same ratio was 1.7 ± 0. 1 when using [U-llC]gIc . Figure 7 is a map of rCMRglc for one particular experiment and one slice. Only correction for the loss of [1lC]C02 has been made . The good contrast between gray and white matter obtained with [l-llC]glc is illustrated. The image compares favor ably to previously published maps of rCMRglc ob tained with eSF]FDG [cf. , e.g., Sasaki et al . (1986) , who have constructed maps of rCMRgic from eSF]FDG data using a method similar to the one applied here] . Figure 8 is a plot of rCBF vs. rCMRglc • Data from the same experiment and the same slice as in Fig. 6 were used. The plot illus trates the strong regional coupling between rCBF and rCMRglc [cf. the methods section, eqs. (7) and (8)] .
DISCUSSION
Interpretation of the results
The acidic IIC metabolites have not been chemi cally identified, but the magnitude as well as the time course of the A VD of these compounds are consistent with loss of mainly [llC]lactate. Further more , our results indicate that, after correction for the small loss of e IC]C02, the rate of glucose oxi dation rather than the total CMRglc is measured by [l-llC]gIc, provided the measuring time is suffi ciently long. The reasons for this interpretation of the data are the following.
FIG . 8. A plot of rCBF vs. rCMRg,c for the data in a central slice containing 11,326 pixels of the 256 x 256 display image matrix. Both the range of rCBF, 0-97 ml/100 g/min, and the range of rCMRg1c, 0-44 f.Lmo1/1 00 g/min, are divided into 128 intervals. The color code for a particular pair of intervals of rCBF and rCMRg,c denotes the fraction of pixels in the original pair of im ages that contains rCBF and rCMRg,c values in the selected ranges. To give a better impression of the gross features of the distribution, the plot is somewhat filtered.
The large initial egress of e IC]C02 before the dip at 15 min found when [U-l lC]glc is used (cf. Fig. 2) is interpreted as mainly a result of the labeling in the carbon-3 and -4 positions, which have been previ ously shown to be the first lost as CO2, before the Krebs cycle in the metabolic pathway (Sacks et aI ., 1983) . The small but detectable egress of [11C]C02 in the same time interval when [l-llC]glc is used may be ascribed to the pentose pathway , where car bon in the 1 position is oxidized. The proportion of glucose metabolised via the pentose shunt is prob ably relatively small in the normal adult brain (Hostetler et aI. , 1970 ; Hawkins et aI ., 1985 ; and Gaitonde et aI. , 1987) . After 15 min, the loss of [llC]C02 from the remaining positions 1, 2, 5, or 6 becomes important and corresponds to the produc tion of CO2 from the Krebs cycle.
Apart from a short delay, the time course of the loss of acidic llC metabolites resembles the time course of the loss of [11C]C02 from carbons 3 and 4. It differs from the time course of the [llC]C02 loss from carbons 1, 2, 5, and 6 in the glucose ring (cf. Fig. 2) . Consequently, the production of these acidic metabolites occurs at an early stage in the metabolic chain, before the Krebs cycle.
The molar ratio found between CMR02 and CMRglc, i.e. , 5.6 ± 0. 9 (mean ± SD), is consistent with 5.3 ± 0.8 given in a compilation by Mazziotta and Phelps (1986) and 5. 5 (median) reported by Sokoloff (1986) . The ratio is less than 6, which in dicates the presence of nonoxidative metabolism of glucose. Mainly lactate and , to a lesser extent, py-J Cereb Blood Flow Me tab. Vol. /0, No. 4. 1990 ruvate are lost from the brain as a result of nonox idative glucose metabolism (see Siesjo, 1978, chap. 4, and Sokoloff, 1986 for reviews). These metabo lites are produced early in the metabolic breakdown of glucose and before the Krebs cycle , and the cor responding labeled compounds should therefore give a detectable A VD of acidic IIC metabolites during an early time period after a bolus injection of labeled glucose. Kloiber and Drewes (1987) have reported that [14C]lactate is the predominant meta bolic product in the venous blood from the brain during the first 10 min after administration of [6-14C]glucose to dogs during hypermetabolic con ditions.
The regional concentration of lactate in the rat brain has been observed to increase appreciably during fu nctional activation (Kuhr and Korf, 1988 ; Ueki et aI. , 1988) . In the three experiments where the acidic llC metabolites were measured, some brain regions were activated by peripheral stimula tion (hand movements). Therefore , one might argue that the A VD of acidic metabolites observed in these cases is due to a large regional loss of [llC]lactate caused by the activation. However, only about 5% of the brain was activated, which could not possibly give a global A VD of the ob served magnitude. No differences were detected in global CMR02, CMRglc (both measured by the Fick principle), or CBF between the experiments with and without stimulation. We therefore conclude that the observed A VD in acidic llC metabolites is caused by global processes.
When the data are not corrected for the loss of ac idic llC metabolites, but only for the loss of [llC]C02, CMRglc obtained with [llC]glucose is compatible with (l/6)CMR02 measured by the Fick principle , i.e., the expected rate of glucose oxida tion when all oxygen is consumed by this process. The parameter estimated with the tracer method de creases slowly when the time interval used for the fit is prolonged . When data are also corrected for the loss of acidic IIC metabolites, CMRglc increases by 12% and becomes close to the value obtained by the Fick principle , i.e., the rate of total CMRglc . Furthermore , the time dependence of the estimate has almost disappeared. As a comparison, using the Fick principle , CMRglc is 11 % larger than (l/6)CMR02•
To motivate the proposal that [l_ IIC]glc measures the rate of glucose oxidation, one can not simply claim that e 1C]lactate leaves the tissue so rapidly that only e IC]metabolites produced by glucose ox idation remain after a sufficiently long time (> 15 min) . On the contrary , the finite A VD of the acidic IIC metabolites detected at 25 min (Fig. 2) shows that a considerable amount of these labeled com pounds must also remain in the tissue at this time . These labeled metabolites will of course be pro duced as long as there is unmetabolized [1 _ 11 C]glc in the plasma and contribute to the tissue radioactivity from which CMRglc is calculated. The following points motivate why the presence of these IIC me tabolites nevertheless have little influence on the CMRg\c , estimated in the time interval considered (0-25 min) .
First, it is the late part of the time-activity curve that determines rCMRglc , because the sensitivity fu nction (Beck and Arnold , 1977) for this model pa rameter increases monotonously with time . The be havior of the tissue time-activity curve and the loss of labeled metabolites in the beginning have little effect on the estimate of CMRglc .
Second, at late times, when the precursor pool is in equilibrium with the tracer concentration in the plasma, which is almost constant in time , rCMRg\c is determined mainly from the slope of the tissue time-activity curve (Patlak et aI ., 1983) , and not fr om the total radioactivity in the tissue.
Third , Fig. 2 indicates that the rate of loss (pro portional to the A VD) of the acidic IIC metabolites increases to a maximum around 15 min and there after decreases slowly with time. The figure shows the A VD of these metabolites expressed as a per cent of Ca *, but at late times this latter quantity is almost constant in time (cf. Figs . 1 and 6) . This result indicates that the acidic IIC metabolites re maining in the tissue are close to an equilibrium state (the rate of loss of these metabolites from the tissue is assumed to be proportional to the concen tration of the metabolites remaining in the tissue). Therefore, the concentration of the remaining acidic IIC metabolites contributes very little to the rate of change of the tissue time-activity curve at late times and , consequently, contributes little to the CMRg\c estimate . In contrast to the kinetic anal ysis made here , an autoradiographic determination of the rate of glucose oxidation based on radiola beled D-glucose requires a correction for the labeled lactate retained in the tissue (cf. Ackermann and Lear, 1989) .
The rate of change of the tissue radioactivity at late times is thus mainly due to the increase in the tissue concentration of IIC metabolites produced by oxidation of [1) lC]glc . It is evident fr om Fig. 1 that these metabolites do not approach any equilibrium, because the loss of [llC]C02 accelerates in the time interval 0-25 min. Apart from [llC]C02, the main part of the IIC metabolites produced by glucose ox idation is expected to remain in the brain during the time period considered because, besides CO2, no measurable loss from the tissue of such metabolites has been reported in the literature . Most of the glu cose metabolites are acidic and , therefore , with our data, we cannot exclude the possibility that other labeled compounds besides e IC] lactate (and [IIC]pyruvate) contribute to the detected acidic component. However, most of these metabolites are produced at a late stage in the metabolic chain, after the pyruvate step, and are accordingly ex pected to contribute substantially only to the late part of the acidic time-activity curve shown in Fig .  2 . Since the labeled metabolites that contribute to this curve have not been chemically identified, we have used the notation "acidic IIC metabolites" for these compounds.
With our present data, the indication that the rate of glucose oxidation rather than the total CMRg\c is measured by [1 _ 11 C]glc can not be tested regionally. This could be achieved with PET using [l-IIC]glc and eSO]02 on the same subjects. It must be stressed that the commonly used glucose analogs [IIC]DG and eSF]FDG measure , provided LC is known, the rate of total glucose consumption, oxi dative or not. Regional variations of the fraction of oxidative metabolism of glucose could therefore be investigated through PET measurements using [1_IIC]glc and, for example, eSF]FDG on the same subjects . If the high SD in CMRglc obtained by the Fick principle is not due to a lower precision in this method, but reflects a real difference between total and oxidative CMRglc, the nonoxidative part must vary more among individuals than the oxidative part of glucose utilization. Also, this effect could be investigated in a double tracer experiment.
The tracer model
The applied tracer model implies of course a sim plification of the tracer kinetics. Many parameters, e.g., the rate constants k2 and k3 ' are strongly de pendent on the applied model and will change when the compartmental model is changed. As discussed earlier, it can be shown with quite general assump tions (Patlak et aI ., 1983) that the time course of a tracer that can be trapped in the tissue will sooner or later assume a very simple form possible to de scribe by two parameters, one of which is CMRglc . This is irrespective of the complexity of the meta bolic pathways of the tracer in the tissue, provided the plasma activity C�(t) varies slowly at late times. Further, the sensitivity fu nction of this pa rameter increases monotonously with time , imply ing that mainly the late part of the uptake curve determines the metabolic rate . Consequently, this parameter is quite independent of the exact com partmental configuration assumed, unless the mea surements are confined to a very short initial time interval following a bolus injection. The time inter val used in this study , 24 min, is sufficient for a good estimate of rCMRglc (cf. Figs . 6 and 7) . The obtained CMRglc value changes very little if the measuring time is diminished to 15 min, but the quality of the rCMRglc map is of course worse, i.e., the precision in the estimate decreases. With this measuring time, the tissue concentration of the acidic IIC metabolites has not equilibrated with the precursor pool, which may aff ect the accuracy of the rCMRglc estimate. If a very small measuring time is chosen, the influence of losses is diminished, but then the amount of metabolized tracer is too small to allow an accurate determination of rCMRglc and the possible effects of oversimplifications in the model can affe ct the result.
If [l-llC]D-glucose is to be a useful tracer for the routine measurement of CMRg1 C ' simultaneous A VD measurements of IIC metabolites can not be performed . Instead , it is necessary to develop a method of estimating the loss of IIC metabolites utilizing the measurements in the present series of experiments. As discussed above, we have found that, after correction for the loss of [llC]C02, [1-llC] 1990) . In these experiments, the following proce dure was applied to correct for the loss of [' IC]C02• It was assumed that the regional accumulated loss of [11C]C02, q';( t ), is proportional to the radioactiv ity remaining in the tissue, C�ss( t ): c<,:: (X,t) = gc(t ) . C�ss(x,t)
The "egress fu nction," gc(t) , was thus assumed to be the same in all regions and in all experiments.
The five experiments using [U-"C]glc treated in this report were utilized to calculate gc as the ratio between the measured average loss of [llC]C02 ob tained with the aid of Eq. (8) and the average tissue radioactivity . To facilitate correction for losses at arbitrary measuring times, the time course of this ratio was also fitted with the expression in Eq. (11), which was found to give a sufficiently adequate de scription of the measured egress fu nction with a minimum of parameters (cf. Fig. 3 ) . For [U-llC]glc , the average parameters aL and bL were found to be 0.021 ± 0.004 and 0.63 ± 0.32 (mean ± SD), respec tively.
However, at very high metabolic rates with large early losses of [,IC]COz, one cannot expect the cu mulative egress to be proportional to the remaining tissue radioactivity. Further, the egress function is empirically an increasing fu nction of time (Fig. 3) . In the extreme case with CMRglc equal to zero, the tissue radioactivity remains in the precursor pool, equilibrates with the plasma radioactivity, and be comes almost a constant fu nction of time . Never theless, use of Eq. (12) will give a corrected tissue radioactivity that increases with time, and results in a positive CMRglc estimate . These two effects will lead to erroneous corrections.
When [l-llC] glc is used, the results presented in Fig. 4 show that the correction for loss of [,IC]C02 can be expressed as d dFt (x , t ) = kdx) . Ct,, (x,t)
where the factor kL was found to be approximately time independent. Use of this equation is more re alistic than use of Eq. (12) above, because Eq. (13) relates the rate of loss of tracer to the tissue con centration of llC metabolites in the same way as , for example , the rate of change of [l-llC]glc in the tissue is related to the concentration of tracer in the plasma via K I [cf. Eq. (1)]. The regional egress rate of ['1C]C02 at late times is expected to be nearly proportional to the rate of glucose oxidation (cf. the Methods section) . Furthermore, the concentration of llC metabolites in the tissue must, at least for low egress rates, be nearly proportional to rCMRglc [cf.
Eq. (2)] . Therefore, the factor KL in Eq. (13) is expected to have a weak spatial variation. Note that the term KL . C� is supposed to describe the loss of [IIC]C02 from the tissue, not the production of [1IC]C02 in the tissue. If the expression above is substituted for dCt(t)ldt in Eq. (2), the solution [Eq. (4)] is modified to It must be pointed out that even when a time independent kL is a good approximation, one should not try to fit this parameter like K I , k2' and k3 • At first sight, the approach of fitting four param eters instead of three might seem straightforward , but actually what one then tries to do is to estimate the ratio between two unobservable quantities, dC"C(t)ldt and C�(t) [Eq. (13) ] . The second quantity is constrained via Eq. (5), but the first is completely undetermined. Therefore , Eq. (14) should be used with a kL determined in advance.
In contrast to the loss of e IC]C02 , the loss of acidic IIC metabolites is not expected to be de scribed equally satisfactorily with the aid of Eq. (13). The rate of loss of ["C]lactate is probably much larger than the average in regions with high rCMRglc , because the fraction of glycolysis with as sociated production of lactate has been shown to be higher in such regions (Fox et aI ., 1988; Kuhr and Korf, 1988; Ueki et aI ., 1988; Ackermann and Lear, 1989) . Therefore , the factor kL in Eq. (13) for the loss of acidic IIC metabolites is expected to have an appreciable regional variation. Also, Fig . 4 shows that the factor kL is more time dependent for acidic IIC metabolites than for ["C]C02, Lu et aI . (1983) used Eq. (13) to describe the loss of labeled metabolites when using [2-14C]D-glucose autoradiographically, but included an extra factor that makes kL rise exponentially with time to a lim iting value . Such an expression may be more real istic (cf. Fig. 4 ) , but one should remember that the time dependence is largest in the beginning, where the loss of metabolites is very small [because here C�(t) is small] . The difference between these ap proaches is thus of minor importance , but a time dependent kL should make it impossible to write the solution in the above simple form [Eq. (14) ] .
Consequently, if the A VD of IIC metabolites and rCBF are not measured in conjunction with the ex periments using [l_ "C]gIc to measure the rate of glucose oxidation, Eq. (14) should be used with a time-independent kL' determined in advance, to compensate for the loss of elC]C02• The measuring time should be 20--25 min, because at this time the concentration of ["C] lactate in the tissue has reached a comparatively stable level and the loss of [IIC]C02 is not too large.
Alternatively, if rCBF is measured in connection with the experiment using [l-"C]gIc, a modified (14) form of Eq. (8) can be used to compensate for the loss of llC metabolites. The factor A VD[C�et(t)]
in Eq. (8) can be expressed as 100 · PAVD[C�et(t)] . C�(t), where the factor PAVD[Cinet(t)]
(measured in this study) is the time course of the AVD of llC metabolites expressed as a percent of the arterial tracer concentration C:(t) (cf. Fig. 2 ).
The use of this procedure rests, besides the assump tions underlying Eq. (8), also on the assumption that the fu nction P A VD is the same in all experi ments.
Conclusions
In conclusion, the use of [l-"C]gIc substantially reduces the early loss of [ 1 1C]C02 observed with [U-IIC]gIc and improves the estimation of rCMRg!c . A detected loss of acidic IIC metabolites is inter preted as loss of mainly ["C]lactate produced by nonoxidative glucose metabolism. Mter correction for the loss of all detected llC metabolites, CMRglc obtained with the tracer method and with the Fick principle agree. With a 24-min measuring time and after correction for the small loss of [11C]C02 only, [l_llC]gIc may be used to measure the rate of glu cose oxidation rather than the total CMRglc' To con firm our interpretation that the detected acidic "C metabolites are mainly ["C]lactate, these com pounds still must be identified chemically. The rates of glucose oxidation and oxygen consumption should be compared regionally. The average loss of [,IC]C02 from the brain is well described by a sim ple kinetic model including a single rate constant to describe the loss. This model can be applied to PET measurements with [l-"C]gIc without simultaneous A VD measurements of the "c metabolites and without measurements of rCBF.
